This result is significant because ED patients are commonly prescribed PDE5i following prostate cancer surgery which in addition to promoting smooth muscle relaxation via the nitric oxide synthase/cGMP pathway may also improve penile morphology and thus erectile function through a SHH dependent mechanism. This evidence concerns the gene SHH and prostate cancer.